All Settlements

Drugs & Pharmacy Settlements

5 active class action settlements in this category.

Pharmaceutical class action lawsuits target drug manufacturers, pharmacies, and healthcare companies that cause harm through dangerous medications, deceptive marketing, or overcharging practices. These settlements may cover side effects from prescription drugs, generic drug price-fixing schemes, or misleading health claims. If you have been affected by a pharmaceutical product that is the subject of a class action, you may be eligible to file a claim and receive compensation.

Largest Settlements

SettlementAmount
Generic Cymbalta Settlement: Up to $10 Per Prescription for ContaminationUndisclosed total; up to $10 per prescription

All Drugs & Pharmacy Settlements

Zantac MDL Dismissal: Judge Rejects Cancer Claims Against Defendants - Class Action Law Updates
drugs-pharmacy

Zantac MDL Dismissal: Judge Rejects Cancer Claims Against Defendants

Zantac MDL dismissed in 2023. Judge rejected cancer claims; no settlement. Eleventh Circuit appeals pending. No claims process available.

Read more about Zantac MDL Dismissal: Judge Rejects Cancer Claims Against Defendants
CVS Faces Major DOJ Lawsuit Over Opioid Prescriptions - Class Action Law Updates
drugs-pharmacy

CVS Faces Major DOJ Lawsuit Over Opioid Prescriptions

DOJ sues CVS Pharmacy in December 2024 for allegedly filling unlawful opioid prescriptions from pill mills, citing patient safety and opioid crisis concerns.

Read more about CVS Faces Major DOJ Lawsuit Over Opioid Prescriptions
Zantac MDL Settlement: GSK Pays $2.2B Over Ranitidine Cancer Claims - Class Action Law Updates
drugs-pharmacy

Zantac MDL Settlement: GSK Pays $2.2B Over Ranitidine Cancer Claims

GSK settles $2.2B in Zantac ranitidine litigation affecting 80,000 lawsuits. MDL 2924 ongoing in federal court with 75,000 state cases in Delaware.

Read more about Zantac MDL Settlement: GSK Pays $2.2B Over Ranitidine Cancer Claims
OptumRx Settles $1.86M TCPA Class Action Over Unsolicited Calls - Class Action Law Updates
drugs-pharmacy

OptumRx Settles $1.86M TCPA Class Action Over Unsolicited Calls

OptumRx settles $1.86M class action for unsolicited prerecorded calls without patient consent. February 2026 settlement covers TCPA violations. File your claim.

Read more about OptumRx Settles $1.86M TCPA Class Action Over Unsolicited Calls
Generic Cymbalta Settlement: Up to $10 Per Prescription for Contamination - Class Action Law Updates
drugs-pharmacy

Generic Cymbalta Settlement: Up to $10 Per Prescription for Contamination

Breckenridge duloxetine settlement offered up to $10 per prescription for generic Cymbalta contaminated with cancer-causing impurities. Learn about eligibility and future refunds.

Read more about Generic Cymbalta Settlement: Up to $10 Per Prescription for Contamination

Looking for settlements you can claim right now?

View Open Settlements